Puma Biotechnology shareholders elect directors, ratify KPMG, approve say-on-pay at 2022 annual meeting

PUMA BIOTECHNOLOGY, INC.

All seven director nominees elected: Auerbach (29.9M for, 0.9M withheld), Wilson (20.4M for, 10.4M withheld).
KPMG ratified as independent auditor for FY2022 with 37.1M votes for, 0.5M against, 0.1M abstain.
Advisory vote on executive compensation approved: 27.1M for, 3.6M against, 0.1M abstain, with 6.95M broker non-votes.
Meeting held June 14, 2022; all proposals passed with broker non-votes on director and say-on-pay proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.